>_ QFI Terminal
Terminal › Stocks › GCTK

GlucoTrack, Inc. (GCTK) Stock

Healthcare · Medical - Instruments & Supplies · IL
$0.49 -38.75%
Last updated Nov 12, 2026 09:31 UTC

GCTK Key Statistics

Market Cap$278,053.44
P/E (TTM)-0.01
P/S (TTM)—
P/B (TTM)0.16
Revenue (TTM)$0.00
EPS (TTM)$-49.16
Dividend Yield—
ROE (TTM)-393.33%
Net Margin0.00%
Gross Margin0.00%
52W High$25.05
52W Low$0.49
Analyst View—
Price Target—
Employees11
Volume73,946

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

CEO: Paul V. Goode. Company website

GCTK — Frequently Asked Questions

What is the GCTK stock price today?

GlucoTrack, Inc. (GCTK) trades at $0.49, down 38.75% on the day, as of Nov 12, 2026 09:31 UTC.

What is GlucoTrack, Inc.'s market cap?

GlucoTrack, Inc. has a market capitalisation of $278,053.44, calculated from the live GCTK share price and shares outstanding.

What is the P/E ratio of GCTK?

GCTK has no meaningful price-to-earnings ratio: GlucoTrack, Inc. lost $49.16 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does GlucoTrack, Inc. make?

GlucoTrack, Inc. generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for GCTK?

GCTK has traded between $0.49 and $25.05 over the past 52 weeks, and the last price is 98.0% below that high.

Is GlucoTrack, Inc. profitable?

Yes. GlucoTrack, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.

What sector is GlucoTrack, Inc. in?

GlucoTrack, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in IL .

Who is the CEO of GlucoTrack, Inc.?

Paul V. Goode is the chief executive of GlucoTrack, Inc., which employs 11 people.

Where can I track GCTK in real time?

QFI Terminal shows GCTK with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See GCTK live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open GCTK in Terminal See plans

Medical - Instruments & Supplies stocks

MDLN Medline Inc. BDX Becton, Dickinson and Company BAX Baxter International Inc. ISRG Intuitive Surgical, Inc. SOLV Solventum Corporation AVTR Avantor, Inc. RMD ResMed Inc. COO The Cooper Companies, Inc. HOLX Hologic, Inc. ATR AptarGroup, Inc. XRAY DENTSPLY SIRONA Inc. WST West Pharmaceutical Services, Inc. NVST Envista Holdings Corp TFX Teleflex Incorporated ICUI ICU Medical, Inc. MMSI Merit Medical Systems, Inc. RGEN Repligen Corporation MLSS Milestone Scientific Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc.